At Notes from the (Legal) Underground, I've been doing some writing about the pre-trial maneuvering of plaintiffs' lawyers in the Vioxx mass-tort litigation. My posts are done from the perspective of a plaintiffs' lawyer, but don't be alarmed: like all lawyers, I'm trained to see both sides, and I'm on high alert for weaknesses in the litigation.
The posts are these:
1. Is the FDA a Toothless Watchdog? (10/07)
2. A Question for Readers: What Do You Want to Know About the Vioxx Case? (including the "Cast of Characters") (10/18)
3. Interesting Facts About the Vioxx Fiasco from Fortune Magazine (10/27)
4. Query: Why Isn't Merck Management Cooperating With the Press Regarding Vioxx? (11/03)
5. Weekly Report #42: Life Goes On (11/06)
6. Live from the Vioxx Conference in Pasadena (11/11)
7. Merck CEO Raymond Gilmartin: Bankruptcy Is Not an Option (11/15)
8. Where's the MDL Panel Meeting Today? Read On to Find Out (11/18)
Some of these are written from the point of view of a neutral observers; others are written from the point of view of a Vioxx lawyer. For those looking for a Vioxx attorney or referral source, follow the links.
Comments